Related Experiment Video
Updated: Oct 18, 2025
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Expression of Interleukin-35 and Type 2 Cytokines in Children with Acute Allergic Asthma
Zhangqiao Cai1, Yuxia He, Jing Yang
1Emergency Department, Affiliated Renhe Hospital of China Three Gorges University, Yichang, Hubei, China.
Background:
Allergic asthma is believed to be a T helper 2 cell (Th2) preponderant response caused by airway hyper-responsiveness. Interleukin-35 (IL-35) is a newly discovered anti-inflammatory cytokine.
Objective:
To determine whether the expression of IL-35 is associated with type-2 inflammation in children with asthma exacerbations.
Methods:
Thirty children (6-12 years old) with acute allergic asthma and twenty healthy controls were enrolled. Sputum was collected from lower airways. IL-35 and type 2 cytokines expression from serum and sputum were measured at mRNA and protein level by real-time PCR and enzyme-linked immunosorbent assay (ELISA), respectively. The sampling and the test were repeated eight weeks after the asthma exacerbation.
Results:
At the time of exacerbation, IL-35 expression decreased significantly in induced sputum and serum than in the controls. The expression of IL-35 was negatively correlated with IL-4, IL-5 and IL-13 expression. The IL-35 from induced sputum increased significantly, whereas type-2 cytokines decreased significantly eight weeks after the exacerbation.
Conclusion:
Our results showed that decreased IL-35 was associated with type-2 cytokines in asthma exacerbations in children, suggesting that IL-35 may be a potential future drug target for asthma exacerbations.
More Related Videos
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: